Multiple trials have reported that CD4+ T cells and CD8+ T cells are active with high proportions of HLA-DR CD3, CD28, and CD38, and increase the expression of the proliferation marker Ki67 in COVID-19 [80,93]. Here, CD8A is linked to COVID-19.